Molecular Formula | C21H23NO6 |
Molar Mass | 385.41 |
Density | 1.265±0.06 g/cm3(Predicted) |
Melting Point | 90-92℃ |
Boling Point | 631.4±45.0 °C(Predicted) |
Flash Point | 335.6°C |
Solubility | Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly) |
Vapor Presure | 8.27E-17mmHg at 25°C |
Appearance | White crystal |
Color | White |
pKa | 3.40±0.10(Predicted) |
Storage Condition | Inert atmosphere,2-8°C |
Refractive Index | 1.579 |
MDL | MFCD01321015 |
Physical and Chemical Properties | Storage Conditions:-15 ℃ WGK Germany:3 |
In vitro study | ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker. PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins. |
Safety Description | S22 - Do not breathe dust. S24/25 - Avoid contact with skin and eyes. |
WGK Germany | 3 |
HS Code | 29189900 |
Introduction | [2-[2-(Fmoc-amino) ethoxy] ethoxy] acetic acid is a key intermediate compound for the synthesis of anti-AIDS drug Irabot and diabetes treatment drug Somalutide. This modified PEG and its homologs can also be used in drug research and development, for example, protein drugs, peptide compounds, liposomes, and small molecule drugs can be modified by coupling reactions. |
use | [2-[2-(Fmoc-amino) ethoxy] ethoxy] acetic acid is an organic synthesis intermediate and pharmaceutical intermediate, which can be used in laboratory research and development and chemical medicine synthesis process. |
biological activity | Fmoc-8-amino-3,6-dioxaoctanoic acid (Fmoc-NH-PEG2-CH2COOH) is a degradable ADC linker used in antibody drug conjugate (ADC) synthesis. Fmoc-8-amino-3,6-dioxaoctanoic acid is also a PEG-based PROTAC linker, which can be used for PROTAC synthesis. |